HK1249142A1 - 測定dna甲基化的分析法和癌症的dna甲基化標記 - Google Patents

測定dna甲基化的分析法和癌症的dna甲基化標記

Info

Publication number
HK1249142A1
HK1249142A1 HK18108557.8A HK18108557A HK1249142A1 HK 1249142 A1 HK1249142 A1 HK 1249142A1 HK 18108557 A HK18108557 A HK 18108557A HK 1249142 A1 HK1249142 A1 HK 1249142A1
Authority
HK
Hong Kong
Prior art keywords
dna methylation
assays
cancer
markers
methylation markers
Prior art date
Application number
HK18108557.8A
Other languages
English (en)
Inventor
Wei Guo
Paolo Piatti
Xiaojing Yang
Xi-Yu Jia
Original Assignee
Zymo Res Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55650678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1249142(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymo Res Corporation filed Critical Zymo Res Corporation
Publication of HK1249142A1 publication Critical patent/HK1249142A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/30Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/331Methylation site specific nuclease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2545/00Reactions characterised by their quantitative nature
    • C12Q2545/10Reactions characterised by their quantitative nature the purpose being quantitative analysis
    • C12Q2545/101Reactions characterised by their quantitative nature the purpose being quantitative analysis with an internal standard/control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2561/00Nucleic acid detection characterised by assay method
    • C12Q2561/113Real time assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • General Chemical & Material Sciences (AREA)
HK18108557.8A 2015-02-24 2018-07-03 測定dna甲基化的分析法和癌症的dna甲基化標記 HK1249142A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562120373P 2015-02-24 2015-02-24
PCT/US2016/019310 WO2016138105A2 (en) 2015-02-24 2016-02-24 Assays to determine dna methylation and dna methylation markers of cancer

Publications (1)

Publication Number Publication Date
HK1249142A1 true HK1249142A1 (zh) 2018-10-26

Family

ID=55650678

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108557.8A HK1249142A1 (zh) 2015-02-24 2018-07-03 測定dna甲基化的分析法和癌症的dna甲基化標記

Country Status (5)

Country Link
US (2) US10801060B2 (zh)
EP (2) EP3262191B2 (zh)
CN (2) CN107592885B (zh)
HK (1) HK1249142A1 (zh)
WO (1) WO2016138105A2 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170356025A1 (en) * 2016-06-14 2017-12-14 Roche Molecular Systems, Inc. Internal control probes for improving pcr assay performance
CN106480210A (zh) * 2016-11-22 2017-03-08 敬善生物科技(上海)有限公司 一种肿瘤循环dna甲基化检测引物
AU2019253569A1 (en) * 2018-04-12 2020-10-29 Singlera Genomics, Inc. Compositions and methods for cancer or neoplasia assessment
CN111363812B (zh) * 2018-12-25 2023-12-19 广州康立明生物科技股份有限公司 基于dmrta2基因的肺癌诊断剂及试剂盒
WO2020180424A1 (en) 2019-03-04 2020-09-10 Iocurrents, Inc. Data compression and communication using machine learning
CN110387417A (zh) * 2019-06-06 2019-10-29 宽盈医疗科技(上海)有限公司 膀胱癌诊断系统、试剂组合和检测尿液中目的基因甲基化水平的方法
CN114929893A (zh) * 2019-06-24 2022-08-19 齐罗马科德公司 差异定量核酸的方法
CN110283889B (zh) * 2019-07-22 2020-10-13 中南大学 一种双基因监控反应体系、试剂盒及其应用
CN110628910B (zh) * 2019-10-17 2023-06-20 湖南大地同年生物科技有限公司 一种膀胱癌驱动基因点突变甲基化联合辅助诊断方法、试剂盒、系统及应用
CN110872631B (zh) * 2019-12-26 2021-08-10 广州市基准医疗有限责任公司 Dna甲基化生物标志物组合、检测方法和试剂盒
CN110923322B (zh) * 2019-12-26 2020-12-01 广州市基准医疗有限责任公司 膀胱癌相关的dna甲基化生物标志物组合和检测试剂盒
AU2021207992A1 (en) * 2020-01-17 2022-09-01 Nzumbe, Inc. Induction of DNA strand breaks at chromatin targets
CN112662765A (zh) * 2020-03-17 2021-04-16 博尔诚(北京)科技有限公司 一种检测6种中国高发癌症的探针组合物
CN111635938B (zh) * 2020-04-30 2022-07-29 广州康立明生物科技股份有限公司 一种肿瘤检测试剂及试剂盒
CN113528672B (zh) * 2021-09-14 2021-11-30 北京求臻医疗器械有限公司 用于膀胱癌早期筛查的引物和探针组合、试剂盒及应用
CN113667757B (zh) * 2021-10-20 2022-02-22 求臻医学科技(北京)有限公司 用于前列腺癌早期筛查的生物标志物组合、试剂盒及应用
CN114507719A (zh) * 2022-02-23 2022-05-17 厦门飞朔生物技术有限公司 一种针对dna甲基化监测的定量分析方法
WO2023175434A1 (en) * 2022-03-15 2023-09-21 Diagenode S.A. Detection of methylation status of a dna sample

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489507A (en) 1988-11-30 1996-02-06 Perkin-Elmer Corporation DNA detection by color complementation
US6391544B1 (en) 1998-05-15 2002-05-21 Abbott Laboratories Method for using unequal primer concentrations for generating nucleic acid amplification products
US20030219774A1 (en) 2001-12-14 2003-11-27 Rahul Sharma Novel human neurotransmitter transporter
CN1200112C (zh) 2002-04-15 2005-05-04 上海市肿瘤研究所 肝癌相关基因启动子CpG岛的甲基化状态及其应用
WO2005074417A2 (en) 2003-09-03 2005-08-18 Salk Institute For Biological Studies Multiple antigen detection assays and reagents
US7569389B2 (en) 2004-09-30 2009-08-04 Ceres, Inc. Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
ES2383970T3 (es) 2003-10-21 2012-06-27 Orion Genomics, Llc Fragmentación enzimática diferencial
US7459274B2 (en) 2004-03-02 2008-12-02 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
EP2290106B1 (en) 2004-03-08 2018-01-03 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
ES2404066T3 (es) 2005-09-21 2013-05-23 Epigenomics Ag Marcadores para la predicción del resultado de un tratamiento con antraciclina
US20070231800A1 (en) 2006-03-28 2007-10-04 Agilent Technologies, Inc. Determination of methylated DNA
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
CN101353695B (zh) * 2007-07-23 2013-05-01 上海市肿瘤研究所 尿沉淀dna甲基化谱式分析诊断膀胱癌的方法和试剂盒
TW200934876A (en) * 2008-02-04 2009-08-16 Changhua Christian Hospital Rapid methylation quantification of the imprinted gene (LIT1/KCNQ10T1)
US20100248228A1 (en) 2008-03-27 2010-09-30 The Curators Of The University Of Missouri Method for detecting DNA methylation in cancer cells
US8211644B2 (en) 2008-07-13 2012-07-03 Ribomed Biotechnologies, Inc. Molecular beacon-based methods for detection of targets using abscription
EP3620532B1 (en) * 2009-04-20 2021-12-22 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer
EP2966181B1 (en) 2009-06-26 2018-02-14 Epigenomics AG Methods and nucleic acids for analysis of bladder carcinoma
AU2010329552B2 (en) 2009-12-11 2015-11-26 Nucleix Ltd Categorization of DNA samples
WO2011101728A2 (en) 2010-02-19 2011-08-25 Nucleix Identification of source of dna samples
EP2542698B1 (en) 2010-03-03 2015-04-22 Zymo Research Corporation Detection of dna methylation
EP2561097A2 (en) * 2010-04-20 2013-02-27 Nucleix Methylation profiling of dna samples
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2922973B1 (en) 2012-11-26 2019-03-20 Clinical Genomics Pty Ltd A method of detecting methylation
CN107223159A (zh) 2014-05-09 2017-09-29 科戴克斯生命股份公司 源自特定细胞类型的dna的检测及相关方法

Also Published As

Publication number Publication date
EP3640341A2 (en) 2020-04-22
EP3640341A3 (en) 2020-08-05
CN107592885B (zh) 2021-04-30
US20210164031A1 (en) 2021-06-03
US20180148776A1 (en) 2018-05-31
US10801060B2 (en) 2020-10-13
EP3262191A2 (en) 2018-01-03
WO2016138105A3 (en) 2016-09-22
WO2016138105A2 (en) 2016-09-01
CN107592885A (zh) 2018-01-16
EP3262191B1 (en) 2019-08-07
EP3640341B1 (en) 2022-07-27
CN113186288A (zh) 2021-07-30
EP3262191B2 (en) 2023-06-14

Similar Documents

Publication Publication Date Title
HK1249142A1 (zh) 測定dna甲基化的分析法和癌症的dna甲基化標記
IL288622A (en) DNA fragmentation pattern analysis suitable clean
HK1232256A1 (zh) 混合物中的組織甲基化模式分析
HK1245345A1 (zh) 腫瘤樣本的多基因分析
HK1219709A1 (zh) 長脫氧核醣核酸片段的多重標記
PT3325669T (pt) Composições e métodos de análise de rna
SG11201707663SA (en) Lyophilization of rna
HK1252222A1 (zh) Dna混合物中組織的單倍型的甲基化模式分析
EP3008181A4 (en) METHOD AND COMPOSITIONS FOR TARGETED DNA MODIFICATION
HK1253057A1 (zh) 實體瘤甲基化標誌物及其用途
IL253160A0 (en) Cancer markers and methods of using them
HK1251414A1 (zh) 用於檢測癌症復發風險的方法和組合物
IL250830A0 (en) Early detection of lung cancer by DNA methylation phenotypes in moist derived cells
IL269178A (en) Methods of amplifying dna to maintain methylation status
SG10201912967YA (en) Determination of nucleic acid methylation
HK1260327A1 (zh) 檢測癌症復發的方法
GB201602210D0 (en) Detection of cancer
HK1253079A1 (zh) 結合癌細胞的dna適配體
PT3452829T (pt) Perm como marcador de cancro endometrial
RS59766B1 (sr) Luženje minerala
GB201504459D0 (en) Isolation of DNA
ZA201702203B (en) Glycosyltransferase gene expression profile to identify multiple cancer types and subtypes
HK1202314A1 (zh) 用於檢測腸癌的標記物及其應用
SG11201608189WA (en) Combinations of cancer therapeutics
GB201401371D0 (en) Marker gene based prognosis of prostate cancer

Legal Events

Date Code Title Description
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)